An experienced R&D team accompanied by distinguished scientists with a track record of success; doing it again.

Leadership

Mark de Souza, PhD
Co-Founder and Executive Chairman
Matt Tindall, MBA
Co-Founder, President and Chief Executive Officer
Bennett Nemser, PhD
Board Observer, Chief Program Officer at Steven & Alexandra Cohen Foundation
Larry Ward, PhD
Director, Flightpath Biosciences Australia Pty Ltd
Mark de Souza, PhD
Co-Founder and Executive Chairman
Matt Tindall, MBA
Co-Founder, President and Chief Executive Officer
Curtis Scribner, MD, MBA
Co-Founder, Chief Medical Officer Emeritus, Head of Regulatory
Alison Long, MD, PhD
Chief Medical Officer
Colleen Johnson, MSc, DABT
Head of Toxicology
Chris Phillips, MS
Head of Chemistry, Manufacturing and Controls
Georgina Kilfoil
Clinical Consultant & Principal at Ashcroft Life Sciences
Monil Shah, PharmD, MBA
Clinical Development Strategy
Kip Vought
Regulatory Strategy
Kim Lewis, PhD
Director, Antimicrobial Discovery Center @ Northeastern University
Yiping W Han, PhD
Professor of Microbial Sciences in Dental Medicine and Microbiology & Immunology @ Columbia University
Magda Feres, DDS, MSc, DMSc
Chair of the Department of Oral Medicine, Infection, and Immunity @ Harvard School of Dental Medicine
Benjamin Wu, DDS, PhD
Chief Scientific Officer @ ADA Forsyth Institute
Elise Courtois, PhD
Director, Single Cell Biology Lab @ The Jackson Laboratory
Charles Chiu, MD, PhD
Professor of Laboratory Medicine and Medicine, Division of Infectious Diseases @ UCSF

Latest News